Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with Temozolomide
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Alabama at Birmingham
Ann & Robert H Lurie Children's Hospital of Chicago
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
National Taiwan University Hospital
China Medical University, China
Unity Health Toronto